GLP-1 receptor agonists are not associated with increased risks for dry age-related macular degeneration or cataract development, according to two recently published studies.The data instead showed significantly reduced risk for cataracts, as well as l…
AMA policy combats ‘deepfake doctors’
“Deepfake doctors” present a threat to patient trust, medicine’s most valuable currency, and regulations must be implemented to protect public health, according to an expert.At its Interim Meeting of the House of Delegates in November, the AMA adopted …
VIDEO: Duravyu provides ‘good, stable visual acuity’ in neovascular AMD phase 2 trial
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discussed results from the phase 2 DAVIO 2 trial on Duravyu in neovascular age-related macular degeneration.Stewart, professor and chairman of ophthalmo…
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement to correct misinfor…
SLT-YAG platform a potential ‘game-changer’ in glaucoma
ORLANDO — In this Healio Video Perspective from the American Academy of Ophthalmology meeting, Jai G. Parekh, MD, MBA, discusses the benefits of the Lumenis Digital Duet 2.0 selective laser trabeculoplasty-YAG platform.“This has, by leaps and bounds, m…
Science Corporation Names Darius Shahida as Chief Strategy Officer
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation, a brain-computer interface company focused on transcending the limits of biology through neural engineering, today announced the appointment of Darius Shahida as Chief Strategy Officer, effective J…